Gross Margin

Universal Health Services will present at three key March conferences, facing investors with robust profits but also cautious analyst outlooks and industry challenges.

Maesa's new Scents Unearth'd line at Target bets on cultural storytelling and accessible luxury to disrupt the mass fragrance market. Is this the future?

Facing massive revenue declines and a shrinking coach network due to GLP-1 drugs, Medifast bets its future on a risky pivot from weight loss to metabolic health.

An upcoming DC workshop highlights how public-private partnerships are modernizing federal facilities, saving energy, and bolstering national security.

Princess Cruises unveils patriotic voyages for America's 250th, its largest-ever Alaska season, a new ship, and a major sale for 2026 travel.

UK brand Aurelia Cellular Vitality launches in the US, betting its science-led Eternacell™ complex can disrupt the booming ingestible beauty industry.

Orbia Netafim launches its Dosing 5G range, using self-learning AI to automate nutrient delivery, boost yields, and advance sustainable agriculture.

With new Series A funding, Daffodil Health's AI platform aims to dismantle the opaque, costly systems that drive up U.S. healthcare spending.

A foodservice supplier's foundation marks one year by planting 373,000 trees and saving vital species, pioneering a new model for corporate responsibility.

Security giant Senstar finalizes its acquisition of 3D LiDAR innovator Blickfeld, a strategic move set to revolutionize security with smarter detection.

Gaxos.ai secures a deal with ByteDance's BytePlus, gaining access to elite AI video models to challenge giants in the booming creator content market.

Fresh off its IPO, Lumexa Imaging's leadership heads to key conferences. Here’s what’s at stake as they pitch their growth strategy to investors.

Ahead of its March 3 earnings call, 908 Devices' strong preliminary results and focus on handheld tech signal a pivotal year for the security innovator.

Ascend Elements' award to TDK Ventures reveals a new VC model, where hands-on partnership is key to building a secure, circular battery supply chain.

A strategic merger creates a new aerospace and defense giant, but existing shareholders face significant dilution in a deal laden with both promise and risk.

As BRC Inc. preps its 2025 earnings report, can its new energy drink line and veteran mission overcome inflation, lawsuits, and declining margins?

Forget simple indicators. A new breed of retail trader uses complex data, automation, and strict risk rules to gain a professional edge in the market.

With a bolstered cash runway from recent funding, Inventiva is all-in on its MASH drug, lanifibranor, racing against giants in a multi-billion dollar market.

After a soft 2025, Graphic Packaging's CEO faces investors. With the stock lagging, all eyes are on whether its green strategy can deliver growth.

The veteran-founded coffee brand is on the clock after its stock price fell below $1.00, triggering a six-month window to brew a market turnaround.